Skip to navigation Skip to content



Noted MS Neurologist Dr. Roland Martin Wins 2023 John Dystel Prize for Multiple Sclerosis Research

April 12, 2023

Roland Martin, MDRoland Martin, MD, a world-class neurologist and investigator, is the winner of the 2023 John Dystel Prize for MS Research. He is being honored for advancing our understanding of immune mechanisms underlying multiple sclerosis and translating them to develop innovative strategies to treat the disease.  

Martin uncovered how key MS susceptibility genes are involved in launching immune attacks on the nervous system and identified specific components of nerve-insulating myelin that are targeted by those attacks. His team has developed an experimental therapy designed to make the immune system ignore those targets but leave the rest of the protective immune system intact. This strategy is now in clinical testing.
Martin is Professor Emeritus at the University of Zurich’s Institute for Experimental Immunology. He also holds positions as Senior Scientist at the Karolinska Institute in Stockholm and Chief Scientific Officer at the biotech company Cellerys® AG.
“Professor Martin has made major contributions to our understanding of the underlying immune activity at work in MS,” said Dr. Bruce Bebo, Executive Vice President of Research at the National Multiple Sclerosis Society. “His team has brought us closer than ever to finding a way to turn off only the destructive immune activities in MS, while retaining the body’s ability to ward off infections.”
Previous Dystel Prize winner Stephen L. Hauser, M.D., nominated Martin for the prize.
“Roland Martin is a remarkably creative physician-scientist and neurologist whose brilliant investigations have profoundly advanced knowledge of the fundamental biology of MS,” he commented. “His discoveries – bridging genetics, epidemiology, and immunology – revealed how inheritance, coupled with critical environmental exposures, can lead to a misdirected immune attack against the nervous system. He has given us a new understanding of how MS might begin.”
Martin’s work has revealed how immune B cells play a role in activating immune T cells to enter the brain and spinal cord and target specific tissue components in MS and has offered clues to how infectious agents or gut bacteria could trigger MS immune attacks. He has also provided care for people with MS throughout his career, has conducted early clinical trials testing novel therapies in MS, and was responsible for making aHSCT available in Switzerland for people with active MS.
In addition to recent leadership positions, Martin served as director of clinical MS research at the University of Hamburg, held staff positions at the National Institutes of Health, and has served as advisor to many organizations in the U.S. and Europe. He received his medical degree from the University of Würtzburg and additional training at the National Institutes of Health, the University of Tübingen, and the University of Maryland. He has authored over 425 papers and book chapters.
Martin will deliver the Dystel Prize lecture and receive the award at the American Academy of Neurology 2023 Annual Meeting, in Boston, MA, on April 24.
About the John Dystel Prize for MS Research
The Dystel Prize is awarded jointly by the National MS Society and the American Academy of Neurology. It was established in 1994 by former Society National Board member the late Oscar Dystel, and his wife the late Marion Dystel, in honor of their son, John Jay Dystel, an attorney whose promising career was cut short by progressive disability from MS, and complications of the disease that lead to his death in June 2003. Read more about other Dystel Prize winners.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.


© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.